For example, epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) and anaplastic lymphoma kinase (ALK)/c-ros oncogene 1 (ROS1) inhibitors have replaced chemotherapy as the first-line treatment of lung cancer [3]. The gene discussed is ALK; the disease is lung cancer.